Literature DB >> 2157799

Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice.

B A Blacklaws1, A A Nash.   

Abstract

Mouse L cell lines constitutively expressing glycoproteins B or D of herpes simplex virus type 1 (LTKgB and LTKgD respectively) were used to study the longevity of the immune response to these viral glycoproteins in mice. Two immunizations with the cell lines were necessary to induce a persisting antibody response (present for over 200 days). Only LTKgD induced a neutralizing at antibody response in mice and this also remained at high titres over 200 days after two inoculations. The presence in mice of precursor cytotoxic T lymphocytes specific for gB expressed in the L cells was also shown up to 270 days after immunization. Mice immunized with the cell lines showed an increased rate of virus clearance from the ear pinna, inoculation with LTKgD resulting in more clearance than LTKgB at 7 days post-immunization. This type of protection was reduced with time after inoculation, until by day 161 there was no significant difference in virus titres between immunized and control groups. However, LTKgD immunization protected against the establishment of latent infections in the ganglia of mice even up to 186 days post-inoculation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157799     DOI: 10.1099/0022-1317-71-4-863

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice.

Authors:  Hyung Hoan Lee; Soung Chul Cha; Dong June Jang; Jun Keun Lee; Dong Wan Choo; Young Sik Kim; Hong Sun Uh; Soo Young Kim
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

2.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.

Authors:  T Hanke; F L Graham; K L Rosenthal; D C Johnson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Identification and comparative sequence analysis of a gene in equine herpesvirus 1 with homology to the herpes simplex virus glycoprotein D gene.

Authors:  M Whalley; G Robertson; C Bell; D Love; M Elphinstone; L Wiley; D Craven
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

4.  Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines.

Authors:  J E Wellington; G L Lawrence; D N Love; J M Whalley
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Application of a transformed cell line constitutively expressing HSV-1 polypeptides for the detection of HSV antibodies in human sera by an enzyme immunoassay.

Authors:  A Sivropoulou; A Vasilaki; M Arsenakis
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus.

Authors:  D N Love; C W Bell; D Pye; S Edwards; M Hayden; G L Lawrence; D Boyle; T Pye; J M Whalley
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.

Authors:  H E Farrell; C S McLean; C Harley; S Efstathiou; S Inglis; A C Minson
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.

Authors:  M A Brehm; R H Bonneau; D M Knipe; S S Tevethia
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 9.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

10.  Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines.

Authors:  V Durmanová; M Sapák; J Kosovský; I Rezuchová; M Kúdelová; M Buc; J Rajcáni
Journal:  Folia Microbiol (Praha)       Date:  2008-05-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.